Göran Landberg Appointed Director of New Centre for Molecular Medicine
Professor Göran Landberg has been appointed director of the new Wallenberg Centre of Molecular and Translational Medicine at the University of Gothenburg. The decision was made by Vice-Chancellor Pam Fredman earlier this week. The new centre is part of a wider effort to once again make Sweden a leading nation in the field of life science.
‘I’m both happy and honoured. This will be a great opportunity to contribute to the development of the field of life science regionally, nationally and also internationally,’ says Göran Landberg, professor of pathology and currently one of six area heads at Sahlgrenska University Hospital.
As a director, Göran Landberg will initially focus on the recruitment of staff for the tenure track positions planned within the framework of the centre. The recruitment of young researchers will to some degree be coordinated with Lund University, Linköping University and Umeå University, all of which are involved in similar initiatives, also with support from the Wallenberg Foundation.
Landberg will be in charge of coordinating the work with the cooperation partners Region Västra Götaland and Astra Zeneca. It will also be his responsibility to create the best possible conditions for the recruited young researchers to develop into world-leading scientists.
‘As vice-chancellor and ultimately in charge of the new centre, I’m very happy with the choice of director. Göran Landberg has the right qualifications for the job,’ says Pam Fredman, Vice-Chancellor of the University of Gothenburg.
As centre director, Landberg will report directly to the vice-chancellor during the development of the new centre.
About Göran Landberg
Göran Landberg is professor of pathology and was recruited to the University of Gothenburg in the spring of 2012. Before moving to Gothenburg, he had started a breast cancer centre at The Christie in Manchester, one of Europe’s largest cancer hospitals.
His research interests include new treatments for difficult forms of breast cancer. As part of his work at the University of Gothenburg, he has also served as one of six area heads at Sahlgrenska University Hospital.
About the centre
Wallenberg Centre of Molecular and Translational Medicine is a new centre at the University of Gothenburg developed in collaboration with Region Västra Götaland and Astra Zeneca. Close cooperation between the actors will ensure that research results will quickly translate into new treatments and benefits to patients.
More than ten tenure track positions for young researchers will be filled at the University of Gothenburg. The recruited researchers will enjoy great conditions and will add to the already successful research at the University of Gothenburg, Astra Zeneca and Sahlgrenska University Hospital. The total investment equals SEK 620 million over a 10-year period. The Wallenberg Foundation has previously decided to contribute SEK 270 million, and Region Västra Götaland SEK 150 million. Astra Zeneca will support with time and resources equalling a value of SEK 40 million, and the University of Gothenburg will contribute SEK 160 million.